EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Optimized monitoring for immune checkpoint inhibitor induced myocarditis using high-sensitivity troponin-T

Dirk Tomsitz, Ulrich Grabmaier, Judith Spiro, Leo Nicolai, Lars E French, Steffen Massberg, Lucie Heinzerling

European Journal of Cancer · 2025

DOI: 10.1016/j.ejca.2024.115186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Dirk Tomsitz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Immune Checkpoint Inhibitors, Myocarditis, Troponin T, Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesministerium für Bildung und Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Checkpoint InhibitorsMyocarditisTroponin TNeoplasmsHumansMaleFemaleMiddle AgedAgedProspective StudiesBiomarkersAdultAged, 80 and over

Stichwörter der Autor:innen

High-sensitivity troponin-TImmune checkpoint inhibitorsMajor adverse cardiac eventMyocarditis

Substanzen

Immune Checkpoint InhibitorsTroponin TBiomarkers

Autor:innen und Institutionen

  • Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany.
  • Department of Medicine I, LMU University Hospital, LMU Munich, Munich, Germany.
  • Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Department of Medicine I, LMU University Hospital, LMU Munich, Munich, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Munich Heart Alliance, Munich, Germany.
  • Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany; Dr. Philip Frost, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
  • Department of Dermatology and Allergy, University Hospital, LMU Munich, Munich, Germany; Department of Dermatology, Friedrich-Alexander University Erlangen-Nürnberg (FAU) and University Hospital Erlangen (UKER), Deutsch…

Förderung

  • Bundesministerium für Bildung und Forschung

Zitieren

APA

Tomsitz, D., Grabmaier, U., Spiro, J., Nicolai, L., French, L. E., Massberg, S., & Heinzerling, L. (2025). Optimized monitoring for immune checkpoint inhibitor induced myocarditis using high-sensitivity troponin-T. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.115186

Vancouver

Tomsitz D, Grabmaier U, Spiro J, Nicolai L, French LE, Massberg S, et al. Optimized monitoring for immune checkpoint inhibitor induced myocarditis using high-sensitivity troponin-T. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2024.115186

BibTeX
@article{Tomsitz2025,
  author = {Tomsitz, Dirk and Grabmaier, Ulrich and Spiro, Judith and Nicolai, Leo and French, Lars E and Massberg, Steffen and Heinzerling, Lucie},
  title = {Optimized monitoring for immune checkpoint inhibitor induced myocarditis using high-sensitivity troponin-T},
  journal = {European Journal of Cancer},
  year = {2025},
  doi = {10.1016/j.ejca.2024.115186}
}
Kostenlos starten →